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doi:10.1016/j.ejvs.2009.02.004Abstract Access site complication rates remain relatively high following interventional
procedures and have not been shown to be reduced by the use of vascular closure devices. This
report describes an ultrasound-assisted technique of deploying one type of vascular closure
device, the StarClose (Abbott Vascular, Illinois, USA). This technique has significantly reduced
failure rates and complication rates since its introduction. The technique is relatively simple
but requires familiarity with the use of ultrasound and the StarClose device.
Crown Copyright ª 2009 Published by Elsevier Ltd on behalf of European Society for Vascular
Surgery. All rights reserved.The StarClose and StarClose SE (Abbott Vascular, Illinois,
USA) vascular closure devices (VCDs) are an alternative to
manual compression following arterial access. The Star-
Close VCD deploys a nitinol clip on the adventitial aspect of
the arterial puncture. It is superior to manual compression,
reduces time to haemostasis, facilitates patient mobi-
lisation and decreases length of stay, but does not reduce
complications.1 It fails in 5.9% of diagnostic cases and 13.2%ridge, MBBS, FRACS (vasc),
patriation General Hospital,
th Australia 5041, Australia.
51852.
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09 Published by Elsevier Ltd on bof interventional cases with a 5.4% risk of vascular
complications.1 This article reports an ultrasound-guided
method of deployment of StarClose, introduced to improve
technical success and reduce vascular complications.
Report
Ultrasound is used to guide arterial puncture. At the end of
the procedure, the catheter or sheath within the common
femoral artery (CFA) is exchanged for the StarClose sheath
and the StarClose applicator is inserted in the usual
manner. The StarClose device has ‘four clicks to closure’.
The first click engages the sheath to the applicator. The
second click deploys a vessel locator.ehalf of European Society for Vascular Surgery. All rights reserved.
Figure 1 Longitudinal image of the common femoral artery (CFA). The vessel locator of the StarClose device can be seen entering
the left-hand side of the image as it is withdrawn.
Ultrasound-Guided StarClose 89Ultrasound is then used to guide deployment. The left
hand is used to hold the images and the right hand is used to
deploy the device, which is quite different from the usual
method of deployment. An initial scanning in a longitudinal
plane is used to identify the CFA with the StarClose sheath
in situ. This casts a large acoustic shadow distally. An imageFigure 2 A longitudinal image shows the vessel locator adjacen
indent the vessel. An acoustic shadow caused by the sheath and dof the CFA is maintained and the vessel locator is pulled
back slowly, using the right hand, until it comes into view
and is brought to the anterior wall of the CFA. The vessel
locator is easily visible as shown in Fig. 1.
Next, the ‘thumb advancer’ is used to deliver the nitinol
clip to the access site. Maintaining an image centred on thet to the anterior wall of the CFA. Upward pressure is seen to
evice is seen distally to the right side of the image.
Table 1 Complication and failure rates following standard
and ultrasound-guided deployment of the StarClose device.
Standard
deployment,
nZ 119
(60.4%)
Ultrasound-
guided deployment,
nZ 78
(39.6%)
Device failure 11 (9.2%) 1 (1.3%) PZ 0.02
Complications 7 (5.9%) 2 (2.6%) PZ 0.23
Combined
complication
or device
failure
14 (11.8%) 2 (2.6%) PZ 0.02
90 P.J. Puckridge et al.vessel locator, this is advanced. Slight tension is applied
maintaining apposition of the vessel locator against the
anterior wall, monitored with ultrasound. The device can
be seen advancing throughout the subcutaneous tissue till it
locks in place with the vessel locator e the third click
(Fig. 2).
Finally, the device is brought up to an angle of 65 and
pushed downwards indenting the anterior wall of the CFA
slightly. The amount of indentation is monitored using
ultrasound. The ‘trigger’ is pressed to deploy the device,
retracting the vessel locator and firing the clip e the fourth
click. The subcutaneous tissue is immediately examined to
identify the nitinol clip which can be seen as an echogenic
image on the anterior wall of the vessel casting a narrow
acoustic shadow. This can also rule out haematoma or false
aneurysm.
All patients undergoing peripheral angiography or
intervention at the Repatriation General Hospital have
demographic procedural and outcome data entered
prospectively into a database. Endpoints for an access site
complication include haematoma, pseudo-aneurysm, arte-
rio-venous fistulae, haemorrhage, arterial occlusion,
infection, nerve injury and venous thrombosis. A non-
randomised series of 197 patients between 01 January 2007
and 01 July 2008 were identified as having StarClose device
deployed; 78 (39.6%) of them underwent the procedure
using the ultrasound-guided method. The device was
considered to have failed if manual compression was
required to achieve haemostasis. Results were analysed
statistically using the Fischer Exact Test.
There was a significant reduction in failure rates and
combined complication or failure rates when the ultra-
sound-guided technique was used (PZ 0.02). Complication
rates were lower with ultrasound guidance but not signifi-
cantly different (PZ 0.23) (Table 1).Discussion
The major advantage of the ultrasound-guided procedure is
that deployment of the device can be visualised. Directly
visualising the vessel locator allows greater accuracy in
deployment position decreasing the risk of misdeployment
within the vessel or superficial to the anterior arterial wall
which may lead to failure or complications. This technique
reduces device failure which, when it occurs, requires
additional compression to achieve haemostasis. Ischaemic
complications reported with StarClose2e4 can be avoided
using this technique. With ultrasound the footplate can be
recaptured and moved past any obstructing plaque, then
redeployed under imaging allowing accurate placement
against the anterior wall of the artery.
The improved results were not thought to represent
a learning curve as the operatorswere experienced in the use
of StarClose. Despite a trend towards lesser complications in
the series, this study is not sufficiently empowered to make
assumptions regarding complication rates. A sample of 200
patients in each group would be required to determine if
complication rates are reduced by ultrasound guidance.
Ultrasound has been reported previously to check effi-
cacy of StarClose deployment5 but not to actually guide
deployment. The described method requires familiarity
with both the StarClose device and ultrasound, but can be
performed by one operator and is an improvement on the
current technique of deployment.
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